Home/Pipeline/MVA-BN HIV

MVA-BN HIV

Prevention of HIV

Phase 2Active

Key Facts

Indication
Prevention of HIV
Phase
Phase 2
Status
Active
Company

About Bavarian Nordic

Bavarian Nordic is a publicly traded vaccine specialist with a firm focus on developing and manufacturing life-saving immunizations. The company has demonstrated strong commercial momentum, particularly in its Travel Health business, and has been a key supplier of a non-replicating smallpox/mpox vaccine for global public health stockpiles. Its strategy leverages a fully integrated model from R&D through manufacturing to address infectious disease threats.

View full company profile